2026-2034年全球非處方寵物藥品市場規模、佔有率、趨勢和成長分析報告

寵物非處方成藥市場預計將從 2025 年的 104.5 億美元成長到 2034 年的 178.7 億美元，2026 年至 2034 年的複合年成長率為 6.15%。

由於寵物飼養量的增加和人們對動物健康意識的提高，全球非處方寵物藥品市場正穩步成長。非處方寵物藥品通常用於治療輕微疾病、寄生蟲感染、過敏和消化器官系統問題，無需處方箋。寵物飼主也越來越願意在寵物保健產品上投入資金，以維護寵物的健康。

推動市場成長的因素包括寵物「擬人化」趨勢的日益增強以及寵物護理產品支出的增加。寵物店、獸醫診所和線上平台提供種類繁多的成藥，讓飼主更容易獲得治療。此外，動物用藥品的進步也提高了這些藥物的有效性和安全性。

隨著全球寵物飼養量的成長，預計該市場將持續擴張。寵物保健產品的創新以及天然草藥的研發正日益受到寵物飼主的青睞。電子商務平台和線上獸醫服務的發展將進一步提升寵物主人取得成藥的便利性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球非處方寵物藥品市場：依藥品類型分類

• 市場分析、洞察與預測
• 跳蚤和蜱蟲防治
• 驅蟲藥和寄生蟲控制藥物
• 止痛藥和抗過敏藥
• 皮膚和毛髮護理
• 牙科護理
• 營養補充品
• 行為和焦慮緩解藥物
• 其他藥物類型

第5章：全球非處方寵物藥品市場：依寵物類型分類

• 市場分析、洞察與預測
• 狗
• 貓
• 鳥
• 魚類和爬蟲類
• 其他寵物類型

第6章：全球非處方寵物藥品市場：依劑型分類

• 市場分析、洞察與預測
• 咀嚼點心
• 膠囊
• 噴
• 軟膏
• 其他劑型

第7章：全球非處方寵物藥品市場：依分銷管道分類

• 市場分析、洞察與預測
• 獸藥
• 寵物專賣店
• 線上零售商
• 其他分銷管道

第8章 全球非處方寵物藥品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AdvaCare Pharma
  • Bimeda
  • Boehringer Ingelheim International
  • Ceva Sante Animale
  • Dechra
  • Elanco Animal Health
  • Heska Corporation
  • Merck & Co
  • Norbrook
  • Nutramax Laboratories Consumer Care
  • PetIQ
  • Phibro Animal Health
  • Vetenex Animal Health
  • Vetoquinol
  • Virbac
  • Zoetis

The Pet OTC Medication Market size is expected to reach USD 17.87 Billion in 2034 from USD 10.45 Billion (2025) growing at a CAGR of 6.15% during 2026-2034.

The global pet OTC medication market has been growing steadily due to increasing pet ownership and rising awareness about animal health. Over-the-counter medications for pets are commonly used to treat minor illnesses, parasites, allergies, and digestive issues without requiring a prescription. Pet owners are increasingly investing in preventive healthcare products to maintain their pets' well-being.

Several factors are driving market growth, including the growing trend of pet humanization and increasing spending on pet care products. The availability of a wide range of OTC medications in pet stores, veterinary clinics, and online platforms has made it easier for pet owners to access treatments. Additionally, advancements in veterinary pharmaceuticals have improved the effectiveness and safety of these medications.

The market is expected to continue expanding as pet ownership rises globally. Innovations in pet healthcare products and the development of natural and herbal medications are gaining popularity among pet owners. The growth of e-commerce platforms and online veterinary services will further increase accessibility to OTC medications for pets.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Medication Type

• Flea And Tick Control
• Dewormers & Parasiticides
• Pain Relievers & Allergy Medications
• Skin And Coat Care
• Dental Care
• Nutritional Supplements
• Behavioral & Anxiety Relief Medications
• Other Medication Types

By Pet Type

• Dogs
• Cats
• Birds
• Fishes & Reptiles
• Other Pet Types

By Dosage Form

• Chews & Treats
• Capsules
• Sprays
• Ointments
• Other Dosage Forms

By Distribution Channel

• Veterinary Pharmacies
• Pet Specialty Stores
• Online Retailers
• Other Distribution Channels

COMPANIES PROFILED

• AdvaCare Pharma, Bimeda, Boehringer Ingelheim International, Ceva Sante Animale, Dechra, Elanco Animal Health, Heska Corporation, Merck Co, Norbrook, Nutramax Laboratories Consumer Care, PetIQ, Phibro Animal Health, Vetenex Animal Health, Vetoquinol, Virbac, Zoetis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET OTC MEDICATION MARKET: BY MEDICATION TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Medication Type
• 4.2. Flea And Tick Control Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dewormers & Parasiticides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pain Relievers & Allergy Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Skin And Coat Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Dental Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Nutritional Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Behavioral & Anxiety Relief Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Other Medication Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET OTC MEDICATION MARKET: BY PET TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet Type
• 5.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Birds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Fishes & Reptiles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Pet Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET OTC MEDICATION MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dosage Form
• 6.2. Chews & Treats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Capsules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Sprays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET OTC MEDICATION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pet Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Retailers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET OTC MEDICATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Medication Type
  • 8.2.2 By Pet Type
  • 8.2.3 By Dosage Form
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Medication Type
  • 8.3.2 By Pet Type
  • 8.3.3 By Dosage Form
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Medication Type
  • 8.4.2 By Pet Type
  • 8.4.3 By Dosage Form
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Medication Type
  • 8.5.2 By Pet Type
  • 8.5.3 By Dosage Form
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Medication Type
  • 8.6.2 By Pet Type
  • 8.6.3 By Dosage Form
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PET OTC MEDICATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AdvaCare Pharma
  • 10.2.2 Bimeda
  • 10.2.3 Boehringer Ingelheim International
  • 10.2.4 Ceva Sante Animale
  • 10.2.5 Dechra
  • 10.2.6 Elanco Animal Health
  • 10.2.7 Heska Corporation
  • 10.2.8 Merck & Co
  • 10.2.9 Norbrook
  • 10.2.10 Nutramax Laboratories Consumer Care
  • 10.2.11 PetIQ
  • 10.2.12 Phibro Animal Health
  • 10.2.13 Vetenex Animal Health
  • 10.2.14 Vetoquinol
  • 10.2.15 Virbac
  • 10.2.16 Zoetis